These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29968789)
21. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin. Gimpl G; Postina R; Fahrenholz F; Reinheimer T Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of milk ejection in cows by oxytocin receptor blockade, alpha-adrenergic receptor stimulation and in unfamiliar surroundings. Bruckmaier RM; Wellnitz O; Blum JW J Dairy Res; 1997 Aug; 64(3):315-25. PubMed ID: 9275252 [TBL] [Abstract][Full Text] [Related]
23. The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. Ohlsson B; Björgell O; Ekberg O; Darwiche G BMC Gastroenterol; 2006 Mar; 6():11. PubMed ID: 16542457 [TBL] [Abstract][Full Text] [Related]
24. Endogenous oxytocin excites phasic contraction of gallbladder in rabbits through oxytocin receptor. Liu CY; Liu JZ; Xie DP; Liu PY; Wang PS Chin J Physiol; 2003 Sep; 46(3):95-101. PubMed ID: 14672277 [TBL] [Abstract][Full Text] [Related]
25. Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design. Bellenie BR; Barton NP; Emmons AJ; Heer JP; Salvagno C Bioorg Med Chem Lett; 2009 Feb; 19(3):990-4. PubMed ID: 19095447 [TBL] [Abstract][Full Text] [Related]
26. Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Koehbach J; O'Brien M; Muttenthaler M; Miazzo M; Akcan M; Elliott AG; Daly NL; Harvey PJ; Arrowsmith S; Gunasekera S; Smith TJ; Wray S; Göransson U; Dawson PE; Craik DJ; Freissmuth M; Gruber CW Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21183-8. PubMed ID: 24248349 [TBL] [Abstract][Full Text] [Related]
27. Discovery of defense- and neuropeptides in social ants by genome-mining. Gruber CW; Muttenthaler M PLoS One; 2012; 7(3):e32559. PubMed ID: 22448224 [TBL] [Abstract][Full Text] [Related]
28. Atosiban, an oxytocin receptor blocking agent: pharmacokinetics and inhibition of milk ejection in dairy cows. Wellnitz O; Bruckmaier RM; Albrecht C; Blum JW J Dairy Res; 1999 Feb; 66(1):1-8. PubMed ID: 10191468 [TBL] [Abstract][Full Text] [Related]
29. The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via G(αi) signalling. Kim SH; MacIntyre DA; Hanyaloglu AC; Blanks AM; Thornton S; Bennett PR; Terzidou V Mol Cell Endocrinol; 2016 Jan; 420():11-23. PubMed ID: 26586210 [TBL] [Abstract][Full Text] [Related]
30. Cligosiban, A Novel Brain-Penetrant, Selective Oxytocin Receptor Antagonist, Inhibits Ejaculatory Physiology in Rodents. Wayman C; Russell R; Tang K; Weibly L; Gaboardi S; Fisher L; Allers K; Jackson M; Hawcock T; Robinson N; Wilson L; Gupta J; Casey J; Gibson KR J Sex Med; 2018 Dec; 15(12):1698-1706. PubMed ID: 30527053 [TBL] [Abstract][Full Text] [Related]
32. Oxytocin and vasopressin in the medial amygdala differentially modulate approach and avoidance behavior toward illness-related social odor. Arakawa H; Arakawa K; Deak T Neuroscience; 2010 Dec; 171(4):1141-51. PubMed ID: 20933576 [TBL] [Abstract][Full Text] [Related]
33. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban. Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081 [TBL] [Abstract][Full Text] [Related]
35. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin. Stam WB; Van der Graaf PH; Saxena PR Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926 [TBL] [Abstract][Full Text] [Related]
36. Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium. Kim SH; Pohl O; Chollet A; Gotteland JP; Fairhurst AD; Bennett PR; Terzidou V Mol Pharmacol; 2017 Apr; 91(4):403-415. PubMed ID: 28188254 [TBL] [Abstract][Full Text] [Related]
37. Effects of atosiban on stress-related neuroendocrine factors. Babic S; Pokusa M; Danevova V; Ding ST; Jezova D J Endocrinol; 2015 Apr; 225(1):9-17. PubMed ID: 25609735 [TBL] [Abstract][Full Text] [Related]
38. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban. Bossmar T J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602 [TBL] [Abstract][Full Text] [Related]
39. Small molecule ligands for oxytocin and vasopressin receptors. Freidinger RM; Pettibone DJ Med Res Rev; 1997 Jan; 17(1):1-16. PubMed ID: 8979247 [No Abstract] [Full Text] [Related]
40. Advances in the design of selective antagonists, potential tocolytics, and radioiodinated ligands for oxytocin receptors. Manning M; Cheng LL; Klis WA; Stoev S; Przybylski J; Bankowski K; Sawyer WH; Barberis C; Chan WY Adv Exp Med Biol; 1995; 395():559-83. PubMed ID: 8714021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]